Home > Careers


Senior/Principal Scientist (FullTime) Apply for this Job

Summary

  • Participate in the establishment of a core drug product formulations department with responsibility for the formulation, process, and drug delivery development activities required for regulatory approval.
  • Provide technical leadership in the areas of aseptic filling, formulation component compatibility, stability, and process development and scale up of parenteral formulations in support of clinical studies and commercial product.
  • Coordinate the activities of contract manufacturers associated with the preparation of drug product, as required. Some travel will be necessary (25%).
  • Prepare and maintain documentation including lab notebooks, scientific reports, summaries, protocols, and regulatory documentation in support of worldwide regulatory submissions.
  • Supervise technical staff including day-to-day activities, personnel development and reviews.
  • Keep current with field of drug product development, formulation and manufacturing through conferences and scientific literature.
  • Advise management of applicable developments in the fields of drug product development/manufacturing as appropriate.
  • Communicate/coordinate activities with Eyetech alliance partners. Travel and represent company when appropriate.

Qualifications

  • BA/BS, MS, Ph.D. degree in chemistry, chemical engineering biochemistry, pharmacy or equivalent.
  • 12+ (BS), 8+ (MS), 5+ (Ph.D.) years experience in pharmaceutical formulation and process development, preferably in biopharmaceutical parenterals.
  • Proven track record of scientific/engineering accomplishments with a demonstrated ability to solve scientific/engineering problems.
  • Demonstrated abilities to multi-task, work in a team-based environment and meet aggressive deadlines.
  • Good oral and written communication skills required.
  • Knowledge of drug development, cGMP compliance and regulatory guidances (ICH, FDA) necessary. Previous experience with IND/NDA filings a plus.


We disclaim any obligation to update the above information, which was last modified on March 22, 2004. Please refer to the Investor Relations – SEC Filings and – Press Releases sections of our web site for more expansive and current information about our company.

© copyrights 2004.
    Eyetech Pharmaceuticals.
 Update Notice | Privacy Policy | Usage Terms